Solid State Characterization of Commercial Crystalline and Amorphous Atorvastatin Calcium Samples
- 30 March 2010
- journal article
- Published by Springer Science and Business Media LLC in AAPS PharmSciTech
- Vol. 11 (2), 598-609
- https://doi.org/10.1208/s12249-010-9419-7
Abstract
Atorvastatin calcium (ATC), an anti-lipid BCS class II drug, is marketed in crystalline and amorphous solid forms. The objective of this study was to perform solid state characterization of commercial crystalline and amorphous ATC drug samples available in the Indian market. Six samples each of crystalline and amorphous ATC were characterized using X-ray powder diffractometry (XRPD), differential scanning calorimetry (DSC), thermogravimetric analysis, Karl Fisher titrimetry, microscopy (hot stage microscopy, scanning electron microscopy), contact angle, and intrinsic dissolution rate (IDR). All crystalline ATC samples were found to be stable form I, however one sample possessed polymorphic impurity, evidenced in XRPD and DSC analysis. Amongst the amorphous ATC samples, XRPD demonstrated five samples to be amorphous ‘form 27’, while, one matched amorphous ‘form 23’. Thermal behavior of amorphous ATC samples was compared to amorphous ATC generated by melt quenching in DSC. ATC was found to be an excellent glass former with Tg/Tm of 0.95. Residual crystallinity was detected in two of the amorphous samples by complementary use of conventional and modulated DSC techniques. The wettability and IDR of all amorphous samples was found to be higher than the crystalline samples. In conclusion, commercial ATC samples exhibited diverse solid state behavior that can impact the performance and stability of the dosage forms.Keywords
This publication has 21 references indexed in Scilit:
- Micronization of atorvastatin calcium by antisolvent precipitation processInternational Journal of Pharmaceutics, 2009
- Solid state evaluation of some thalidomide raw materialsInternational Journal of Pharmaceutics, 2009
- Solid form screening – A reviewEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS processInternational Journal of Pharmaceutics, 2008
- Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) processEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- PHARMACOKINETICS OF ATORVASTATIN AND ITS HYDROXY METABOLITES IN RATS AND THE EFFECTS OF CONCOMITANT RIFAMPICIN SINGLE DOSES: RELEVANCE OF FIRST-PASS EFFECT FROM HEPATIC UPTAKE TRANSPORTERS, AND INTESTINAL AND HEPATIC METABOLISMPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2006
- Polymorphism and Patents from a Chemist's Point of View [1]Published by Wiley ,2006
- Drugs as materials: valuing physical form in drug discoveryNature Reviews Drug Discovery, 2004
- Superheating effects during the melting of crystallites of syndiotactic polypropylene analysed by temperature-modulated differential scanning calorimetryPolymer, 1998
- Studies on Powdered Preparations. XVII. Dissolution Rate of Sulfonamides by Rotating Disk MethodCHEMICAL & PHARMACEUTICAL BULLETIN, 1966